{"id":1018340,"date":"2026-11-06T08:39:39","date_gmt":"2026-11-06T13:39:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/"},"modified":"2026-11-06T08:39:39","modified_gmt":"2026-11-06T13:39:39","slug":"cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/","title":{"rendered":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PARSIPPANY, N.J., Nov.  06, 2026  (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong><br \/>\n              <em><br \/>\n                <u>Thursday, November 12<\/u><br \/>\n              <\/em><br \/>\n            <\/strong><br \/>\n            <sup><br \/>\n              <strong><br \/>\n                <em><br \/>\n                  <u>th<\/u><br \/>\n                <\/em><br \/>\n              <\/strong><br \/>\n            <\/sup><br \/>\n            <strong><br \/>\n              <em><br \/>\n                <u> at 8:30 a.m. EST<\/u><br \/>\n              <\/em><br \/>\n            <\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%\">Domestic:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%\">1-844-676-2922<\/td>\n<\/tr>\n<tr>\n<td>International:<\/td>\n<td>1-412-634-6840<\/td>\n<\/tr>\n<tr>\n<td>Webcast:<\/td>\n<td>\n            <a href=\"https:\/\/event.choruscall.com\/mediaframe\/webcast.html?webcastid=jEvPktYr\" rel=\"nofollow\" target=\"_blank\">Webcast Link<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About CorMedix<br \/><\/strong>CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field-based medical and commercial infrastructure deployed in hospitals, clinics and infusion centers. For more information visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UL5Yk3zK4Sa6eMpSgWws0b2IkgCWJ5k09oDWN-1MZPcxqpcYfXLcFUJWiL5BAd_wwl0wwdOeMvO4nDaW8A8d4GpfZ-98_sPLOoiUfGc3CFY=\" rel=\"nofollow\" target=\"_blank\">www.cormedix.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Dan Ferry<br \/>Managing Director<br \/>LifeSci Advisors<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=idkwvi_1Hi1Q7jmSdymxR85AtL0HsZact829Xd75mVQgeo-S0J_a9za0zOI62d5-EfVZC1XkmXQ8a6qOj1i6mERIB7lHaLnjWhQfY7v5lkP2UrGdBkG8BFkACVWTlvXW\" rel=\"nofollow\" target=\"_blank\">daniel@lifesciadvisors.com<\/a><br \/>(617) 430-7576<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWU0MTRmNzgtMWIwMS00MmE0LTgxOTctMjYwMjAzOTRkYmVhLTUwMDA2NTY3OC0yMDI2LTExLTA2LWVu\/tiny\/CorMedix-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PARSIPPANY, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time. Thursday, November 12 th at 8:30 a.m. EST Domestic: 1-844-676-2922 International: 1-412-634-6840 Webcast: Webcast Link \u00a0 \u00a0 About CorMedixCorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field-based medical and commercial infrastructure &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1018340","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PARSIPPANY, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time. Thursday, November 12 th at 8:30 a.m. EST Domestic: 1-844-676-2922 International: 1-412-634-6840 Webcast: Webcast Link \u00a0 \u00a0 About CorMedixCorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field-based medical and commercial infrastructure &hellip; Continue reading &quot;CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-06T13:39:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026\",\"datePublished\":\"2026-11-06T13:39:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/\"},\"wordCount\":156,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/\",\"name\":\"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\",\"datePublished\":\"2026-11-06T13:39:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk","og_description":"PARSIPPANY, N.J., Nov. 06, 2026 (GLOBE NEWSWIRE) &#8212; CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the third quarter ended September 30, 2026, before the market opens on Thursday, November 12, 2026, and will host a corporate update conference call at 8:30 a.m. Eastern Standard Time. Thursday, November 12 th at 8:30 a.m. EST Domestic: 1-844-676-2922 International: 1-412-634-6840 Webcast: Webcast Link \u00a0 \u00a0 About CorMedixCorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases in the United States. CorMedix is focused on selling and marketing products in institutional settings of care in the US and has field-based medical and commercial infrastructure &hellip; Continue reading \"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-06T13:39:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026","datePublished":"2026-11-06T13:39:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/"},"wordCount":156,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/","name":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==","datePublished":"2026-11-06T13:39:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTkyNyM3OTUwMjg0IzUwMDA2NTY3OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cormedix-therapeutics-to-report-third-quarter-2026-financial-results-and-provide-a-corporate-update-on-november-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1018340"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1018340\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1018340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1018340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1018340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}